Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Stefano Pierini, Renzo Perales-Linares, Mireia Uribe-Herranz, Jonathan G. Pol, Laurence Zitvogel, Guido Kroemer, Andrea Facciabene & Lorenzo Galluzzi. (2017) Trial watch: DNA-based vaccines for oncological indications. OncoImmunology 6:12.
Read now
Read now
Jonathan Pol, Norma Bloy, Florine Obrist, Alexander Eggermont, Jérôme Galon, Wolf Hervé Fridman, Isabelle Cremer, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial Watch. OncoImmunology 3:4.
Read now
Read now
Articles from other publishers (25)
Simon Hawlina, Robert Zorec & Helena H. Chowdhury. (2023) Potential of Personalized Dendritic Cell-Based Immunohybridoma Vaccines to Treat Prostate Cancer. Life 13:7, pages 1498.
Crossref
Crossref
Alexis A. Ellis, Sean M. Geary & Aliasger K. Salem. (2023) Heterologous prime-boost vaccine using antigen-loaded microparticles and adenovirus (encoding antigen) enhances cellular immune responses and antitumor activity. International Journal of Pharmaceutics 638, pages 122932.
Crossref
Crossref
Simon Hawlina, Helena H. Chowdhury, Tomaž Smrkolj & Robert Zorec. (2022) Dendritic cell-based vaccine prolongs survival and time to next therapy independently of the vaccine cell number. Biology Direct 17:1.
Crossref
Crossref
Dia Advani, Sudhanshu Sharma, Smita Kumari, Rashmi K. Ambasta & Pravir Kumar. (2022) Precision Oncology, Signaling, and Anticancer Agents in Cancer Therapeutics. Anti-Cancer Agents in Medicinal Chemistry 22:3, pages 433-468.
Crossref
Crossref
Prajakta Nimsarkar, Pooja Gulhane & Shailza Singh. 2022. Systems Biomedicine Approaches in Cancer Research. Systems Biomedicine Approaches in Cancer Research
129
163
.
Maria Adamaki & Vassilios Zoumpourlis. (2021) Immunotherapy as a Precision Medicine Tool for the Treatment of Prostate Cancer. Cancers 13:2, pages 173.
Crossref
Crossref
Vanessa Acebes-Fernández, Alicia Landeira-Viñuela, Pablo Juanes-Velasco, Angela-Patricia Hernández, Andrea Otazo-Perez, Raúl Manzano-Román, Rafael Gongora & Manuel Fuentes. (2020) Nanomedicine and Onco-Immunotherapy: From the Bench to Bedside to Biomarkers. Nanomaterials 10:7, pages 1274.
Crossref
Crossref
Pritish Kumar Panda, Shivani Saraf, Ankita Tiwari, Amit Verma, Sarjana Raikwar, Ankit Jain & Sanjay K. Jain. (2019) Novel Strategies for Targeting Prostate Cancer. Current Drug Delivery 16:8, pages 712-727.
Crossref
Crossref
Ashwin C. Parenky, Archana Akalkotkar, Nihal S. Mulla & Martin J. D'Souza. (2019) Harnessing T-cell activity against prostate cancer: A therapeutic microparticulate oral cancer vaccine. Vaccine 37:41, pages 6085-6092.
Crossref
Crossref
Afshin Moradi, Srilakshmi Srinivasan, Judith Clements & Jyotsna Batra. (2019) Beyond the biomarker role: prostate-specific antigen (PSA) in the prostate cancer microenvironment. Cancer and Metastasis Reviews 38:3, pages 333-346.
Crossref
Crossref
Ren-You Pan, Wen-Hung Chung, Mu-Tzu Chu, Shu-Jen Chen, Hua-Chien Chen, Lei Zheng & Shuen-Iu Hung. (2018) Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens. Journal of Immunology Research 2018, pages 1-9.
Crossref
Crossref
Natalie Fekete, Ariane V. Béland, Katie Campbell, Sarah L. Clark & Corinne A. Hoesli. (2018) Bags versus flasks: a comparison of cell culture systems for the production of dendritic cell–based immunotherapies. Transfusion 58:7, pages 1800-1813.
Crossref
Crossref
Md Kamal Hossain, Kamrun Nahar, Osaana Donkor & Vasso Apostolopoulos. (2018) Immune-based therapies for metastatic prostate cancer: an update. Immunotherapy 10:4, pages 283-298.
Crossref
Crossref
Elaine Harris. (2018) Immunotherapeutics for the treatment of prostate cancer: a patent landscape based on key therapeutic mechanisms of actions. Pharmaceutical Patent Analyst 7:1, pages 47-57.
Crossref
Crossref
Gilles Plourde. 2018. Prostate Cancer. Prostate Cancer
71
92
.
Jitka Fucikova, Michal Podrazil, Ladislav Jarolim, Pavla Bilkova, Michal Hensler, Etienne Becht, Zdenka Gasova, Jana Klouckova, Jana Kayserova, Rudolf Horvath, Anna Fialova, Katerina Vavrova, Klara Sochorova, Daniela Rozkova, Radek Spisek & Jirina Bartunkova. (2017) Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer. Cancer Immunology, Immunotherapy 67:1, pages 89-100.
Crossref
Crossref
Sheri McMahon. (2016) Minimizing Hazards Associated With Live-Virus Immunotherapeutic Cancer Vaccines. Clinical Journal of Oncology Nursing 20:6, pages 602-604.
Crossref
Crossref
Zachary Hamilton & J. Kellogg Parsons. (2016) Prostate Cancer Prevention: Concepts and Clinical Trials. Current Urology Reports 17:4.
Crossref
Crossref
Martin J. D’Souza, Rikhav P. Gala, Ruhi V. Ubale, Bernadette D’Souza, Trinh Phuong Vo, Ashwin C. Parenky, Nihal S. Mulla, Sucheta D’Sa, Marissa D’Souza, Kim Braz-Gomes, Nigel D’Souza, Maurizio Chiriva-Internati & Susu Zughaier. 2015. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies
89
122
.
Said Abdallah Al-Mamari & Salim Said Al-Busaidy. 2015. Urological Cancer Management. Urological Cancer Management
29
55
.
Jeffrey S. Weber. (2014) Current Perspectives on Immunotherapy. Seminars in Oncology 41, pages S14-S29.
Crossref
Crossref
Ignacio Melero, Gustav Gaudernack, Winald Gerritsen, Christoph Huber, Giorgio Parmiani, Suzy Scholl, Nicholas Thatcher, John Wagstaff, Christoph Zielinski, Ian Faulkner & Håkan Mellstedt. (2014) Therapeutic vaccines for cancer: an overview of clinical trials. Nature Reviews Clinical Oncology 11:9, pages 509-524.
Crossref
Crossref
Kawther K. Ahmed, Sean M. Geary & Aliasger K. Salem. (2014) Applying biodegradable particles to enhance cancer vaccine efficacy. Immunologic Research 59:1-3, pages 220-228.
Crossref
Crossref
Karim Y Helmy, Shyam A Patel, George R Nahas & Pranela Rameshwar. (2013) Cancer immunotherapy: accomplishments to date and future promise. Therapeutic Delivery 4:10, pages 1307-1320.
Crossref
Crossref
Stephen Lott. (2013) Specialty pharmacy’s expanding role in prostate cancer management. Pharmacy Today 19:10, pages 53-55.
Crossref
Crossref